Gao et al. also found that LEF1-AS1, as a miR-10a-5p regulatory factor, enhances the expression of MSI1 in liver cancer cells by activating the AKT signaling pathway, and promotes resistance to chemotherapy. This evidence concerns the gene AKT1 and liver cancer.